ALLERGAN INC. — Revenue by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/e8101f94-3d8e-467c-b29d-bade3a496fec/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2014 | $7.1B | 2014-01-01 – 2014-12-31 | evidence 0000850693-15-000002 |
| FY 2013 | $6.2B | 2013-01-01 – 2013-12-31 | evidence 0000850693-14-000002 |
| FY 2012 | $5.5B | 2012-01-01 – 2012-12-31 | evidence 0000850693-14-000002 |
| FY 2011 | $5.1B | 2011-01-01 – 2011-12-31 | evidence 0000850693-14-000002 |
| FY 2010 | $4.8B | 2010-01-01 – 2010-12-31 | evidence 0001193125-11-050632 |
| FY 2009 | $4.4B | 2009-01-01 – 2009-12-31 | evidence 0001193125-10-043126 |
| FY 2008 | $4.3B | 2008-01-01 – 2008-12-31 | evidence 0001193125-10-043126 |
| FY 2007 | $3.9B | 2007-01-01 – 2007-12-31 | evidence 0001193125-10-043126 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).